Symptoms of disturbed eating behavior risk: Gender and study factors in a cross-sectional study of two Norwegian medical schools
Abstract
BACKGROUND
Studies about medical student's stress associated with disturbed eating behavior are scarce.
OBJECTIVES
To study the explanatory role of curricular factors and distress in disturbed eating behavior among medical students and whether this varies according to gender, study stage, curriculum model, study stress and mental distress.
METHODS
The cross-sectional sample surveyed consisted of Norwegian medical students at two faculties with different curricular models (traditional and integrated). The total response rate was 64% (1044/1635). We tested differences in disturbed eating behavior symptoms (EDS) and their correlates using stepwise linear regression analysis.
RESULTS
In total, 18.3% were cases of disturbed eating behavior symptoms, including 23.5% of female and 5.6% of male participants. Disturbed eating behavior symptoms were independently associated with the medical school stress factors "medical school is cold and threatening" (β = 0.07, p = .041), "worries about work and competence" (β =0.15, p < .001) and "worries about finances and accommodation" (β = 0.07, p = .018), in addition to female gender (β = 0.30, p < .001), mental distress (β = 0.17, p < .001), and body mass index (β = 0.28, p < .001). The variables explained 28.9% of the variance in disturbed eating behavior symptoms, and medical school stress contributed 9%. "Worries about work and competence" was more important among the female students.
CONCLUSIONS
Nearly one in five female medical students…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.